MARC record from Internet Archive

LEADER: 03857cam 2200769 a 4500
001 ocm39891533
003 OCoLC
005 20200512041331.0
008 980915s1999 ja a b 001 0 eng
010 $a 98045054
040 $aDNLM/DLC$beng$cDLC$dNLM$dC#P$dVAM$dBAKER$dNLGGC$dBTCTA$dYDXCP$dGEBAY$dOCLCO$dOCLCF$dOCLCQ$dOCLCO$dOCLCQ$dOCLCO$dOCLCA
016 7 $a9815133$2DNLM
020 $a0876308043
020 $a9780876308042
035 $a(OCoLC)39891533
050 00 $aRC350.H47$bH47 1999
060 00 $a2000 F-619
060 10 $aWM 402$bH534 1999
082 00 $a616.8/0461$221
084 $a44.38$2bcl
245 00 $aHerbal medicines for neuropsychiatric diseases :$bcurrent developments and research /$cedited by Shigenobu Kanba and Elliott Richelson.
260 $aTokyo :$bSeiwa Shoten ;$aPhiladelphia :$bBrunner/Mazel,$c℗♭1999.
300 $ax, 144 pages :$billustrations ;$c23 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and indexes.
505 0 $aCh. 1. Use of herbal medicine for treating psychiatric disorders in Japan -- Ch. 2. Pharmacologic studies of himbacine and huperzine A: Potential use in cholinergic replacement therapy -- Ch. 3. Neuropharmacologic activity of constituents isolated from Chinese medicinal plants -- Ch. 4. A double-blind control study of huperzine A and piracetam in patients with age-associated memory imparement and dementias -- Ch. 5. Medicinal plants: A potential source of new psychotherapeutic drugs -- Ch. 6. Indian medicinal plants as a source of CNS active drugs.
505 0 $aCh. 7. Ginkgo preparations: biochemical, pharmaceutical, and medical perspectives -- Ch. 8. The herbal preparations Kangenkaryu and shen yun wan reduce brain oxidative stress -- Ch. 9. Effect of herbal medicine on learning disturbances in senescence-accelerated mice.
650 0 $aHerbs$xTherapeutic use.
650 0 $aNeuropsychopharmacology.
650 0 $aNervous system$xDiseases$xChemotherapy.
650 0 $aMental illness$xChemotherapy.
650 7 $aHerbs$xTherapeutic use.$2fast$0(OCoLC)fst00955386
650 7 $aMental illness$xChemotherapy.$2fast$0(OCoLC)fst01016553
650 7 $aNervous system$xDiseases$xChemotherapy.$2fast$0(OCoLC)fst01036100
650 7 $aNeuropsychopharmacology.$2fast$0(OCoLC)fst01036504
650 17 $aNeuropsychiatrie.$2gtt
650 17 $aNeurofarmacologie.$2gtt
650 17 $aPsychofarmaca.$2gtt
650 17 $aExtracten.$2gtt
650 07 $aPsychische Sto rung.$2swd
650 07 $aPhytotherapie.$2swd
650 07 $aAufsatzsammlung.$2swd
650 07 $aNervensystem.$2swd
650 07 $aKrankheit.$2swd
650 07 $aPsychopharmakon.$2swd
650 07 $aPhytopharmakon.$2swd
650 12 $aMental Disorders$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D001523Q000188
650 22 $aHerbal Medicine.$0https://id.nlm.nih.gov/mesh/D029001
650 22 $aNervous System Diseases$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D009422Q000188
650 22 $aPlant Extracts$xpharmacology.$0https://id.nlm.nih.gov/mesh/D010936Q000494
650 22 $aPlant Extracts$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D010936Q000627
700 1 $aKanba, Shigenobu.
700 1 $aRichelson, Elliott.
856 42 $3Publisher description$uhttp://catdir.loc.gov/catdir/enhancements/fy0652/98045054-d.html
938 $aBaker & Taylor$bBKTY$c37.95$d37.95$i0876308043$n0003212380$sactive
938 $aBaker and Taylor$bBTCP$n98045054
938 $aYBP Library Services$bYANK$n1584416
029 1 $aAU@$b000014149114
029 1 $aGEBAY$b6193239
029 1 $aNLGGC$b173765513
029 1 $aNLM$b9815133
029 1 $aNZ1$b2407957
029 1 $aYDXCP$b1584416
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 96 OTHER HOLDINGS